160 related articles for article (PubMed ID: 3929829)
1. Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma.
Tran-Thang C; Mannucci PM; Schneider P; Federici A; Bachmann F
Br J Haematol; 1985 Oct; 61(2):307-14. PubMed ID: 3929829
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
4. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
6. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
7. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
[TBL] [Abstract][Full Text] [Related]
8. A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.
Mazurier C; Dieval J; Jorieux S; Delobel J; Goudemand M
Blood; 1990 Jan; 75(1):20-6. PubMed ID: 2104761
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand's disease: case report and review of literature.
Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
[TBL] [Abstract][Full Text] [Related]
10. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
11. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
Goudemand J; Mazurier C; Marey A; Caron C; Coupez B; Mizon P; Goudemand M
Br J Haematol; 1992 Feb; 80(2):214-21. PubMed ID: 1550779
[TBL] [Abstract][Full Text] [Related]
13. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies.
Mannucci PM; Lombardi R; Bader R; Horellou MH; Finazzi G; Besana C; Conard J; Samama M
Blood; 1984 Sep; 64(3):614-21. PubMed ID: 6432075
[TBL] [Abstract][Full Text] [Related]
14. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma.
Rao KP; Kizer J; Jones TJ; Anunciado A; Pepkowitz SH; Lazarchick J
Arch Pathol Lab Med; 1988 Jan; 112(1):47-50. PubMed ID: 2447850
[TBL] [Abstract][Full Text] [Related]
16. Investigation of a case of subtype IIC von Willebrand disease: characterization of the variability of this subtype.
Mazurier C; Mannucci PM; Parquet-Gernez A; Goudemand M; Meyer D
Am J Hematol; 1986 Jul; 22(3):301-11. PubMed ID: 3087159
[TBL] [Abstract][Full Text] [Related]
17. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
19. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
20. Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy.
López-Fernández MF; López-Berges C; Martín R; Nieto J; del Rio F; López-Borrasca A; Batlle J
Scand J Haematol; 1986 Mar; 36(3):302-8. PubMed ID: 3486452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]